HENNEMAN JOHN B III has filed 14 insider transactions across 3 companies since June 2023.
Most recent transaction: a purchase of 5000 shares of Orthofix Medical Inc. ($OFIX) on May 07, 2026.
Activity breakdown: 5 open-market purchases and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 7, 2026 | Orthofix Medical Inc. | $OFIX | HENNEMAN JOHN B III | Not found | P | Common Stock | 5000 | $12.26 | 90,809.0000 | 39,766,000 | 5.83% | 0.01% |
| May 1, 2026 | Anika Therapeutics, Inc. | $ANIK | HENNEMAN JOHN B III | Not found | P | Common Stock | 5000 | $14.66 | 54,871.0000 | 14,419,000 | 10.03% | 0.03% |
| June 20, 2025 | Anika Therapeutics, Inc. | $ANIK | HENNEMAN JOHN B III | Director | A | Common Stock | 14164 | $0.00 | 49,871.0000 | 14,721,000 | 39.67% | 0.10% |
| June 18, 2025 | Orthofix Medical Inc. | $OFIX | HENNEMAN JOHN B III | Not found | A | Common Stock | 18841 | $0.00 | 83,706.0000 | 38,134,000 | 29.05% | 0.05% |
| June 5, 2025 | Aprea Therapeutics, Inc. | $APRE | HENNEMAN JOHN B III | Director | A | Common Stock | 1045 | $0.00 | 10,229.0000 | 5,993,866 | 11.38% | 0.02% |
| June 5, 2025 | Aprea Therapeutics, Inc. | $APRE | HENNEMAN JOHN B III | Director | A | Stock Options (Right to Buy) | 4185 | $0.00 | 4,185.0000 | 5,993,866 | 9999.99% | 0.07% |
| July 9, 2024 | Anika Therapeutics, Inc. | $ANIK | HENNEMAN JOHN B III | Director | A | Common Stock | 5771 | $0.00 | 35,707.0000 | 14,656,000 | 19.28% | 0.04% |
| June 20, 2024 | Aprea Therapeutics, Inc. | $APRE | HENNEMAN JOHN B III | Director | A | Common Stock | 1045 | $0.00 | 9,184.0000 | 4,198,326 | 12.84% | 0.02% |
| June 20, 2024 | Aprea Therapeutics, Inc. | $APRE | HENNEMAN JOHN B III | Director | A | Stock Options (Right to Buy) | 4185 | $0.00 | 4,185.0000 | 4,198,326 | 9999.99% | 0.10% |
| June 18, 2024 | Orthofix Medical Inc. | $OFIX | HENNEMAN JOHN B III | Not found | A | Common Stock | 15152 | $12.87 | 63,914.0000 | 36,729,258 | 31.07% | 0.04% |
| March 13, 2024 | Aprea Therapeutics, Inc. | $APRE | HENNEMAN JOHN B III | Director | P | Tranche B Warrant | 3430 | $0.00 | 3,430.0000 | 3,617,607 | 9999.99% | 0.09% |
| March 13, 2024 | Aprea Therapeutics, Inc. | $APRE | HENNEMAN JOHN B III | Director | P | Tranche A Warrant | 3430 | $0.00 | 3,430.0000 | 3,617,607 | 9999.99% | 0.09% |
| March 13, 2024 | Aprea Therapeutics, Inc. | $APRE | HENNEMAN JOHN B III | Director | P | Common Stock | 6860 | $7.29 | 8,139.0000 | 3,617,607 | 536.36% | 0.19% |
| June 14, 2023 | Anika Therapeutics, Inc. | $ANIK | HENNEMAN JOHN B III | Director | A | Common Stock | 6500 | $0.00 | 29,936.0000 | 14,787,000 | 27.74% | 0.04% |